And that's another thing with Cotara - everyone clings to these hopes about HCV and Cotara - when the announcements were vague or not what was expected. FDA Cotara meeting been talked about for a year and all of a sudden it turns into waiting on written feedback. Many on here start saying how this is a positive. Well tell me this - in the past (think govt contract extension, Dios...etc.), whenever an announcement by mgmt has been vague or not what was previously said, when have they EVER come through to the upside or in a positive way? Sorry - but I question everything, and they are guilty until proven innocence. Thinking something is a positive with PPHM when something is announced that is vague or has limited info hasn't gotten me or anybody no where but a whole lot of disappointment and losses.
Market Data 
Markets 
AI
